ATEA PHARMACEUTICALS INC (AVIR)

US04683R1068 - Common Stock

3.52  +0.1 (+2.92%)

After market: 3.55 +0.03 (+0.85%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.00351.40M48.60M
Operating Expenses
125.30M120.01M111.20M119.50M36.70M
Research and Development
78.28M70.09M62.40M73.70M15.00M
Selling, General, and Administrative Expenses
47.02M49.92M48.70M45.80M21.60M
Operating Income
-125.30M-120.01M-111.20M231.90M12.00M
Interest Income/Expense
27.54M29.22M11.20M200.00K100.00K
Non Recurring Items
-75.20M-44.15M-19.50M-93.50M-23.00M
Income Before Taxes
-172.96M-134.94M-119.50M138.60M-10.90M
Income Tax
1.05M1.02M-3.60M17.40MN/A
Net Income
-174.01M-135.96M-115.90M121.20M-10.90M
EBITDA
-124.87M-119.59M-110.90MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-2.07-1.63-1.391.37-0.13
Non GAAP EPS
-2.07-1.64-1.401.36N/A
 
Statistics
Profit Margin
N/AN/AN/A34.49%-22.43%
Operating Profit Margin
N/AN/AN/A65.99%24.69%

All data in USD

Charts